~" Shunt infection remains the foremost problem of shunt implantation after mechanical malfunctions. Diversionary cerebrospinal fluid shunt implantation has a high complication rate, with 5% to 15% of such shunts becoming infected. Of these infections, 70% are diagnosed within 1 month after surgery and more than 90% within 6 months. Shunt infection in the vast majority of cases is therefore a complication of shunt surgery. The authors review their experience with shunt implantation during two time periods. From January, 1978, to December, 1982, 302 children with hydrocephalus underwent 606 operations. Among these children, 47 (15.56%) developed a proven shunt infection, with an incidence of infection per procedure of 7.75%. As a result of this study, a new protocol for shunt procedures involving modifications in the immediate pro-, intra-, and postoperative management of children undergoing shunt implantation was initiated. With this new protocol, 600 children underwent a total of 1197 procedures between January, 1983, and December, 1990. The incidence of shunt infection decreased dramatically, with two infections (0.33%) in 600 patients and a per-procedure rate of 0.17%. The overall annual risk of a shunt infection in the pediatric neurosurgical unit is currently 1.04%. KEY WORDS 9 hydrocephalus 9 ventriculoperitoneal shunt shunt infection 9 operative protocol I NFECTION remains a serious complication of shunt implantation, with a patient mortality rate ranging from 30% to 40%? 3.42 while those who survive risk intellectual, cognitive, and neurological deficits. 35 Infection has been reported to occur in 10% to 15% of shunt procedures; ~-''32'36 however, some authors have described lower infection rates ranging from 2% to 5%.I,10,11,27,39,40 Many factors have been associated with shunt infection, including the age of the patient, 3"~3"2~' 3~ the etiology of the hydrocephalus, j3 and the type of shunt imp!anted. 7''5'2s Other authors have emphasized the importance of the surgeon's experience? 3 Most studies concerning the use of prophylactic antibiotic medications are subject to criticism, 1' 2"6"9' 10"16-19' 2L23' 27.31.41.42 and there is no definitive evidence that prophylactic antibiotic medications reduce shunt infection rates. Some other factors (possibly influenced by the surgical team), such as timing of the operation, duration of surgery, number of operations per patient, number of people in the operating room, and the length of time during which the shunt material is exposed to the atmosphere, have not been studied until now.
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In November, 1982, a retrospective analysis of the shunt infection rate in Marseille, France, revealed that a high proportion (7.75%) of shunts became infected; 99% of these infections were diagnosed within 6 months of shunt implantation, supporting a basic premise that infection of a shunt is a complication of shunt surgery. As a result of this study, there was a review involving all personnel concerned with the pro-, intra-, and postoperative care of patients undergoing a shunt procedure. This included the neurosurgeons, neuroanesthesiologists, nursing staff, and microbiologists. The baseline incidence of shunt infection and the type of responsible organisms were known; using this information, together with data from the literature identifying risk factors for shunt infection, we devised a protocol for shunt implantation. This prospective study was initiated in January, 1983. The effect of this new protocol on the incidence of shunt infection was then audited prospectively. This study demonstrates the efficacy of this protocol.
Clinical Material and Methods
For the purposes of this study, infection rates were compared in two consecutive series of patients with hydrocephalus studied prior to and following the introduction of a new protocol designed to reduce the incidence of shunt infections. The first group of patients was admitted to the pediatric neurosurgical unit between January, 1978, and December, 1982, and the second group between January, 1983, and December, 1990. In each patient, hydrocephalus was diagnosed by ultrasonography, computerized tomography, or magnetic resonance imaging.
Patients studied included those undergoing primary shunt implantation and those admitted for a shunt revision. In each case, the age and sex of the child, the etiology of the hydrocephalus, the operative procedure, the indication for operation in patients having a shunt revision, and the type of shunt system implanted was recorded on a computer printout for subsequent analysis. In the vast majority of patients (99%), a ventriculoperitoneal shunt was inserted, with the most frequently used valve being a membrane type. During shunt insertion, cerebrospinal fluid (CSF) was sent for Gram staining and subsequent culture; patients found to have infected CSF were excluded from subsequent analysis.
Diagnosis of Shunt Infection
A postoperative shunt infection was defined as an infection confirmed within 6 months of operation and was diagnosed if there was inflammation along the length of the shunt, wound discharge, or wound dehiscence. Signs of meningitis, ventriculitis, or nonfocal systemic indications of infection were also investigated for possible infection of the implanted material. Patients with abdominal symptoms or signs, including distention, intra-abdominal cysts, poor absorption of CSF, or abdominal pain or tenderness, were also investigated because these could be due to a shunt infection. Peripheral blood samples and CSF were analyzed (differential white blood cell count and Gram staining) and cultured for aerobes and anaerobes in suspected cases of shunt infection. Serum C-reactive protein and antistaphylococcal antibody titers were studied. After discharge from the hospital, each patient was reviewed on an outpatient basis and follow-up monitoring ranged from 6 months to 8 years.
Protocol for Shunt Implantation Initiated in 1983
An outline of the protocol for shunt implantation used in our hospital beginning in 1983 is presented in Table 1 .
Preoperative Preparation of Patients. Children admitted for either shunt insertion or shunt revision were carefully assessed from a general medical point of view; if an intercurrent infection was diagnosed or if there was a localized skin problem, shunt insertion was deferred until the patient's condition had improved. In patients where urgent treatment of hydrocephalus was required and a general medical problem contraindicated shunt placement, a period of temporary external ventricular drainage was preferred over definitive shunt implantation until the problem had been rectified. Antibiotic medications were not routinely given in the preoperative period. All patients admitted for shunt insertion or revision underwent a hair shampoo the evening before and the morning of the operation using an aqueous povidoneiodine (Betadine) preparation. Neonates and infants were not routinely shaved regardless of whether the operation was for implantation of a new shunt or revision of an existing shunt. In older children admitted for a shunt revision, a limited area of the head was shaved by the surgeon in the anesthesia room immediately before the patient was transferred to the operating theater. The scalp and skin were then prepared with aqueous povidone-iodine or chlorhexidine in neonates while the surgeon scrubbed.
Intraoperative Precautions Against Shunt Infection. Operating schedules were prepared so that shunt implantation was carried out early in the day prior to other neurosurgical procedures. Neonates, infants, and young children were operated on before older children, regardless of whether the procedure was a primary shunt insertion or a revision. No more than four shunt procedures were planned per day. It was proposed that each shunt procedure should take no more than 20 to 40 minutes.
The number of people in the operating room was reduced to four: the surgeon and assistant, the anesthesiologist, and a circulating nurse. To avoid possible contamination of the instrumentation and materials, there was no scrub nurse; the sterile equipment was opened at the last minute by the surgeon or assistant. Shunt implantation was carried out by a neurosurgeon with considerable experience with both the selection and use of shunt materials and the operative techniques required for shunt insertion.
The surgeon chose shunt equipment appropriate for the age of the patient and the etiology of the hydrocephalus. Presterilized and packaged material was not opened until just prior to implantation to avoid prolonged exposure of the shunt material and possible air contamination. After the packaging was opened and before insertion, the shunt was immersed in a gentamicin bath. Formal testing of the valve for patency or verification of the opening pressure was avoided because of the risk of introducing infection.
A sterile adhesive drape was used to secure conventional drapes and expose the minimum area possible. Two small skin incisions were made without an intermediate incision. Hemostasis was secured and subcutaneous hemorrhage avoided. The abdominal incision was made first to minimize the length of time the cranial wound was open. The preassembled shunt was placed in position and the exposed distal catheter was covered by a sterile drape during cannulation of the lateral ventricle and insertion of the ventricular catheter. The valve was carefully positioned in the subgaleal space to avoid skin damage from the shunt material. After shunt insertion, the cranial wound was closed in a single layer using interrupted resorbable sutures. The peritoneal catheter was placed in the right paracolic gutter after opening of the peritoneum under direct vision, and the abdomen was closed in layers in the normal manner.
Throughout the operation the wounds were irrigated with a diluted solution of aqueous povidone iodine, and all shunt materials were rinsed with gentamicin prior to implantation. Each patient was given cloxacillin or oxacillin in a dose of 100 mg/kg intravenously before the skin incisions were made, usually at the time of anesthesia induction.
Postoperative Period. The nursing staff ensured that the patient's head was positioned correctly to avoid pressure on the cranial wound and shunt valve. This was particularly important in premature babies and neonates. Antibiotic medications were not administered in the postoperative period. The patient's hair was washed the morning after surgery and again before discharge using aqueous povidone iodine. Dressings were changed every 2 days using strictly aseptic techniques. Patients were hospitalized for a mean of 4 days for a primary shunt implantation and a mean of 2 days for a shunt revision.
Results

Patients Treated Before Revision of Protocol
From January, 1978, to December, 1982, 606 operations involving shunt implantation were performed in 302 children (130 patients presented with hydrocephalus secondary to myelomeningocele). During this period, 47 children (22 boys and 25 girls) developed a proven shunt infection. Infection was more common in infants; 26 patients were under 2 years of age and, of these, 17 were under 1 year. Twenty-seven patients (57%) developed the infection within 1 month of the operation; infection was confirmed in 40 patients (85%) within 4 months of surgery and in only seven patients (15%) after the 4th month. Of those with a shunt infection, hydrocephalus was congenital in 23, was acquired in 13, was obstructive because of an intracranial tumor in 10, and was of unknown origin in one.
In total, 59 organisms were found in the 47 children, as multiple organisms were cultured in nine. The most common organism was Staphylococcus epidermidis (44%), while S. aureus accounted for 23% of the infections. The other organisms grown were Enterabacter, Enterococcus, S. haemolyticus, Acinobacter, Pseudomonas aeruginosa, and Candidas albicans. Overall, infection occurred in 47 patients (15.56%) and the incidence of infection per procedure was 7.75%.
Patients Treated After Revision of Protocol
From January, 1983, to December, 1990, 600 patients (345 boys and 255 gifts) had a total of 1197 operations (43 children presented with hydrocephalus secondary to myelomeningocele). Of the 600 patients, 482 underwent primary shunt implantation. During the study period, 226 underwent only one operation and 374 underwent a total of 971 revisions. In two patients the shunts were revised after treatment of a shunt infection, and in two the revisions followed unexplained pyrexia. We did not find that shunt reinsertion after infection was associated with an increased risk of shunt infection.
The majority (59% or 353) of the patients were more than 1 year old; 194 patients (32%) were less than 6 months old and 53 (9%) were aged between 6 months and 1 year. One-third (200) of the patients developed hydrocephalus because of an intracranial tumor; the other causes of hydrocephalus included intraventricular hemorrhage, infection, spina bifida aperta, or an intracranial malformation. In approximately 20% of the cases the etiology of the hydrocephalus was unknown.
Overall, infection was confirmed in two patients, resulting in an infection rate of 0.33% per patient and 0.17 % per procedure. Two additional patients had postoperative pyrexia and, despite repeated cultures of CSF and peripheral blood, no causative organism was grown. Nevertheless, each had the shunt removed, a temporary period of external ventricular drainage, and implantation of a new shunt when afebrile. One of the two patients with a confirmed shunt infection was a 13-year-old girl with von Recklinghausen's disease and an optic pathway tumor; this patient developed hydrocephalus and underwent shunting. As a result of a mechanical shunt problem, she had four shunt revisions 7 months later and immediately postoperatively developed a fever; on analysis, Enterobacter was isolated from the CSF. After a temporary period of external drainage and systemic antibiotic medications, a new shunt was inserted when the CSF was sterile and the white blood cell count was less than 10/cu mm. The other patient was an infant born prematurely at 31 weeks who weighed 1.4 kg, with a stage III intraventricular hemorrhage and secondary hydrocephalus. Two weeks after shunt implantation, the infant became pyrexial and a shunt infection due to S. aureus was confirmed by CSF analysis and blood culture. This baby was also treated by shunt removal, external ventricular drainage, and systemic antibiotic medications and was then reshunted 2 weeks later after normalization of the CSF; the infant made good progress thereafter.
Discussion
Surgical Technique
We have demonstrated here that, with a meticulous surgical technique and modifications to the pre-, intra-, and postoperative care, it is possible to reduce significantly the incidence of shunt infection. In our recent experience, we have seen that introduction of a relatively simple protocol for shunt implantation has reduced the per-procedure infection rate from 7.75% to 0.17% in patients undergoing a primary shunt placement or a shunt revision. The majority of shunt infections are observed within 3 months of shunt insertion and are a result of direct contamination at the time of surgery. We agree with Welch 4~ that shunt infection is a potentially preventable complication of shunt surgery. In accordance with data in other reports collected between 1978 and 1982 (Table 2) in which the infection rate per patient ranged from 3.2% to 27%, 1"2"10" 13"20"23"27"40 the infection rate was 15.56% in our patients treated within that period. The number of patients included in each of these studies ranged from 48 to 410; thus, infection rates per procedure ranged from 2.6% to 14% as compared to 7.75% in our series.
After introduction of our new protocol in 1983, the incidence of shunt infection was dramatically reduced from 15.56% to 0.33% per patient and from 7.75% to 0.17% per procedure. Overall, these results are encouraging and lend support to the hypothesis that shunt infection is potentially preventable. In addition, our results compare favorably with infection rates per procedure reported in contemporary series, including those of In agreement with other studies, more than one-half of the infections in the group treated between 1978 and 1982 occurred in children less than 2 years old; 3'~3'~9 M. Choux, el a/ and Raimondi, et al, , 28 found that the use of a one-piece shunt system diminished the rate of infection, especially in patients aged less than 2 years; consequently, we avoid the use of connectors whenever possible. In addition, investigation of shunt malfunction by tapping the shunt reservoir was strictly limited in this study to patients in whom an infection was suspected because of the inherent risk of introducing infection. This view is in contrast to that of Noetzel and Baker, 26 who in a combined retrospective and prospective study showed that no early or late complications occurred in 91 patients with a total of 209 diagnostic tap procedures. Leggate, et aL, 22 reported no complications in cases in which a separate reservoir had been inserted for diagnostic tap procedures.
In accord with the report of George, et al., ~3 who found that the experience of the surgeon was the single most important factor in the reduction of shunt infection rates, we believe that a shunt procedure should be carried out only by an experienced neurosurgeon. In contrast, Renter, et al., 29 reported that the experience of the surgeon does not result in a statistically lower rate of infection.
The majority (44%) of infections in our study were caused by S. epidermidis: in the literature this incidence varies between 50% and 75%.~4.",2~,24~-~,39 Staphyh)coccus aureus was implicated in 20% to 25% of reported cases, 4"5' 2839 and we observed the same incidence (23%). In our study a variety of organisms were cultured; in nine (19%) of the 47 patients with shunt infection, more than one organism was grown from the same culture, a slightly higher incidence of polymicrobial infection than reported by Shapiro, et al." Staphylococci are a frequent cause of shunt infection; they are thought to form discrete colonies within the silicone shunt tubing and have been shown to secrete a mucopolysaccharide that protects the colony and ensures adherence to the shunt material? ~4 Other organisms isolated include Gram-negative bacilli 4 and Gram-positive bacilliJ 33
Prophylactic Antibiotics
There is no clearly defined role for prophylactic antibiotic medications in the prevention of shunt infection (Table 3) . Despite the number of investigators who have compared the prevalence of infection in patients with and without antibiotic coverage, no study withstands scientific scrutiny and most of the early trials were reported as sequential studies. 1,21,n_3,31,34,38 According to Haines, 16' 17 an infection rate between 0.8% and 5.7% in clean neurosurgical operations is acceptable; more recently, Tenney, el al., 37 and Young and Lawner 4~ have reported infection rates of 2.6% and 3.6%, respectively, in neurosurgical procedures performed without antibiotic prophylaxis. In studies involving shunt implantation, it has been estimated that perhaps as many as 1600 patients would require antibiotic medications to achieve a 50% reduction in the shunt infection rate. 37 Haines and Taylor,~9 despite demonstrating reduction in shunt infection rates (five of 39 patients with placebo and two of 39 treated with antibiotic medications) were unable to show a statistically significant reduction. Other reports in which infection rates are disproportionately high and which have demonstrated no apparent benefit from antibiotic prophylaxis may be negative because of an unduly high burden. 6'32 '42 We chose to use prophylactic antibiotic medications guided by our findings in the cases studied between 1978 and 1982. Cloxacillin and oxacillin are in our opinion the most appropriate antibiotic medications because of their narrow spectrum, bactericidal properties, and high affinity for plasma proteins which facilitates antibacterial activity throughout the operation. In agreement with the experimental work of Burke, 9 we gave the antibiotic intravenously before the operation was begun. Although inconclusive results have been obtained in studies where topical antibiotics are used, TM we soaked the shunt material in gentamicin prior to implantation; in our view, this reduced the electrostatic properties of the silicone tubing which favor adherence of bacteria.
We have demonstrated that attention to detail and meticulous surgical technique are important if a high 
